Table 3 Crude COVID-19 outcomes among confirmed cases by sociodemographic characteristics, risk category and risk criteria.
From: Comparison of COVID-19 outcomes among shielded and non-shielded populations
COVID-19 hospitalisation N = 3348a | COVID-19 ICU admission N = 3348a | COVID-19 case-fatality N = 3846b | |||||||
|---|---|---|---|---|---|---|---|---|---|
Not admitted | Admitted | p value | Not admitted | Admitted | p value | Alive | Dead | p value | |
N = 1687 | N = 1661 | N = 3226 | N = 122 | N = 2819 | N = 1027 | ||||
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||
Age group (years) | < 0.0001 | < 0.0001 | < 0.0001 | ||||||
0–24 | 97 (83.62) | 19 (16.38) | 116 (100.00) | 0 | 116 (100.00) | 0 (0.00) | |||
25–44 | 410 (76.92) | 123 (23.08) | 520 (97.74) | 12 (2.26) | 526 (98.50) | 8 (1.50) | |||
45–64 | 553 (51.59) | 519 (48.41) | 990 (92.35) | 82 (7.65) | 1003 (91.77) | 90 (8.23) | |||
≥ 65 | 630 (38.65) | 1000 (61.35) | 1600 (98.28) | 28 (1.72) | 1174 (55.83) | 929 (44.17) | |||
Sex | < 0.0001 | ||||||||
Male | 579 (41.12) | 829 (58.88) | < 0.0001 | 1322 (93.96) | 85 (6.04) | < 0.0001 | 1105 (68.08) | 518 (31.92) | |
Female | 1108 (57.11) | 832 (42.89) | 1904 (98.09) | 37 (1.91) | 1717 (77.10) | 509 (22.90) | |||
Deprivation quintile | < 0.0001 | 0.29 | 0.0004 | ||||||
1 (most deprived) | 566 (43.44) | 737 (56.56) | 1250 (96.08) | 51 (3.92) | 1046 (70.34) | 441 (29.66) | |||
2 | 332 (54.07) | 282 (45.93) | 592 (96.57) | 21 (3.43) | 531 (78.90) | 142 (21.10) | |||
3 | 235 (50.98) | 226 (49.02) | 438 (95.01) | 23 (4.99) | 394 (72.03) | 153 (27.97) | |||
4 | 204 (51.00) | 196 (49.00) | 390 (97.50) | 10 (2.50) | 341 (72.40) | 130 (27.60) | |||
5 (most affluent) | 353 (61.61) | 220 (38.39) | 556 (97.03) | 17 (2.97) | 507 (75.90) | 161 (24.10) | |||
Risk category | < 0.0001 | 0.0001 | < 0.0001 | ||||||
Low | 791 (66.41) | 400 (33.59) | 1125 (94.54) | 65 (5.46) | 1130 (93.08) | 84 (6.92) | |||
Moderate | 828 (44.54) | 1031 (55.46) | 1807 (97.20) | 52 (2.80) | 1485 (64.90) | 803 (35.10) | |||
Shielded | 71 (23.59) | 230 (76.41) | 294 (98.33) | 5 (1.67) | 204 (59.30) | 140 (40.70) | |||
Moderate risk criteria | |||||||||
Chronic respiratory disease | 205 (45.35) | 247 (54.65) | 0.02 | 439 (97.34) | 12 (2.66) | 0.29 | 420 (88.79) | 53 (11.21) | < 0.0001 |
Heart disease | 149 (37.72) | 246 (62.28) | < 0.0001 | 388 (98.23) | 7 (1.77) | 0.049 | 330 (74.16) | 115 (25.84) | 0.7 |
Hypertension | 404 (42.57) | 545 (57.43) | < 0.0001 | 922 (97.26) | 26 (2.74) | 0.10 | 836 (78.87) | 224 (21.13) | < 0.0001 |
Diabetes | 161 (35.31) | 295 (64.69) | < 0.0001 | 432 (94.95) | 23 (5.05) | 0.11 | 398 (80.73) | 95 (19.27) | < 0.0001 |
Weakened immune system | 2 (16.67) | 10 (83.33) | 0.04 | 12 (100.00) | 0 | – | 6 (50.00) | 6 (50.00) | 0.13 |
≥ 70 years of age | 587 (40.37) | 867 (59.63) | < 0.0001 | 1445 (99.45) | 8 (0.55) | < 0.0001 | 1035 (54.10) | 878 (45.90) | < 0.0001 |
Shielding criteria | |||||||||
Severe respiratory disease | 33 (19.64) | 135 (80.36) | < 0.0001 | 165 (99.40) | < 5 | – | 111 (55.78) | 88 (44.22) | < 0.0001 |
Specific cancers | 10 (25.64) | 29 (74.36) | 0.003 | 39 (100.00) | 0 | – | 27 (62.79) | 16 (37.21) | 0.16 |
Pregnant, severe heart disease | – | – | – | – | – | – | – | – | – |
Immunosuppressive therapy | 14 (21.88) | 50 (78.12) | < 0.0001 | 61 (95.31) | < 5 | – | 42 (62.69) | 25 (37.31) | 0.07 |
Solid organ transplant | 2 (11.76) | 15 (88.24) | 0.003 | 16 (94.12) | < 5 | - | 11 (61.11) | 7 (38.89) | 0.37 |
Rare diseases and IEM | 12 (33.33) | 24 (66.67) | 0.06 | 35 (97.22) | < 5 | – | 23 (52.27) | 21 (47.73) | 0.003 |
Renal dialysis | 12 (40.00) | 18 (60.00) | 0.33 | 30 (100.00) | 0 | – | 23 (76.67) | 7 (23.33) | 0.83 |
